ImmunityBio’s latest clinical findings reveal a significant development in the ongoing battle against non-muscle-invasive bladder cancer, with three-year follow-up data suggesting that combining Anktiva with
Editor’s Note: Patient Worthy is proud to share this article, originally written by Katie Tat, from our friends at Elephants & Tea. To see the
As reported on Science Daily, a recent clinical study suggests that a traditional Chinese herbal remedy may offer a unique advantage in treating major depressive
FibroBiologics Inc, a clinical-stage biotechnology company, has announced a significant breakthrough in regenerative medicine by submitting a Phase 1/2 Investigational New Drug (IND) application to
Editor’s Note: Patient Worthy is honored to share Michelle Patidar’s patient story, provided to us by our friends at Elephants & Tea. To see the
My chronic health journey is super complicated. When I first started experiencing my symptoms I wouldn’t tell anyone what I was feeling. I would wake
When pharmaceutical companies develop medications for serious diseases like prostate cancer, few anticipate how those treatments might transform care for entirely different patient populations. Yet,
Altimmune has released updated 48-week results from its phase 2 trial of pemvidutide, a GLP-1/glucagon dual receptor agonist being developed for metabolic dysfunction-associated steatohepatitis (MASH),
CRISPR Therapeutics has announced encouraging early results for zugocaptagene geleucel (zugo-cel), its investigational allogeneic CAR T therapy targeting CD19, in both autoimmune diseases and hematologic
As reported on PharmaBiz, Amneal Pharmaceuticals, in collaboration with mAbxience, has received U.S. Food and Drug Administration (FDA) approval for two denosumab biosimilars: Boncresa (referencing
As reported on Science Daily, a groundbreaking study suggests that customizing breast cancer screening based on individual risk factors may outperform the traditional one-size-fits-all approach
Coya Therapeutics has achieved an important regulatory milestone with U.S. FDA acceptance of an Investigational New Drug (IND) application for COYA 302, marking the advancement
In a recent statement, the U.S. Food and Drug Administration (FDA) has authorized regular approval to rucaparib (Rubraca) for adults with metastatic castration-resistant prostate cancer
A new oral medication has demonstrated remarkable effectiveness in treating hereditary angioedema (HAE) attacks, offering patients significantly faster symptom relief compared to existing options. According
Incyte has announced encouraging top-line findings from its pivotal Phase III frontMIND trial, evaluating tafasitamab (marketed as Monjuvi/Minjuvi) in combination with lenalidomide and the standard
Researchers at Oregon Health & Science University have made a significant breakthrough in the fight against acute myeloid leukaemia (AML), discovering that combining a standard
I’ve always known that I wanted to help people. Growing up as the son of a veterinarian and a high school teacher who later became
Iowa University researchers at its Children’s Hospital led the effort that found a new target. According to the Iowa Carver College of Medicine, to date,
Jessica Glaspie was born and raised in Zion, IL and currently resides in the DFW area in Texas. She has been living with HIV for 15 years and advocating for over 10 years. At just 22 years old she visited the doctor, complaining of swollen lymph nodes in her neck. Her physician drew some blood and did a biopsy. When the results came back, the doctor delivered harrowing and unexpected news: She had tested positive for HIV. Jessica is the author of the memoir "Life, Love, and HIV" and takes great pride in her advocacy work as an educator and motivational speaker. She is a single mother of 3 beautiful, HIV negative children and loves traveling!
If you are interested in sharing your healthcare journey, click the link: bit.ly/4dV7gru
#HIV #shareyourstory #patientworthy #lifelovehiv
CSNK2A1 Foundation #raresiblings #SiblingsMatter💬 Sibling Voices Matter
The Sibling Panel Summary from our July Conference is now live on our website! This powerful conversation highlights the experiences, challenges, and perspectives of siblings growing up alongside a loved one with OCNDS.
From connection to advocacy, these insights remind us why siblings play such an important role in our community.
👉 Read the summary here: loom.ly/GbqdPVE
💙 Thank you to the siblings who shared their voices and helped move this conversation forward.
#OCNDS #CSNK2A1 #BoldBreakthroughs #SiblingPanel #SiblingsMatter
#Be The Match. Your stem cells can save a life. Now normally collected through blood like donating blood. You must be 40 or under to join the registry. A simple saliva sample on a cue tip does the trick. Call the @NMDP and ask for a kit to be sent to you.
© Copyright 2024 Patient Worthy
Sign Up With a Patient Worthy Account and Share Your Rare Story
- OR -
Make a difference, share your experiences and get paid. Opt-in and join Patient Worthy's panel for paid opportunities such as surveys, market research, patient advisory panels and more.
- OR -
Make a difference, share your experiences and get paid. Opt-in and join Patient Worthy's panel for paid opportunities such as surveys, market research, patient advisory panels and more.
